CIK: 0001839948 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value ($000): $875,508 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGON | CG ONCOLOGY INC | 3,670,206 | $95,425 | 10.9% | $40.67 | -40.8% | COMM | 156944100 |
| TNGX | TANGO THERAPEUTICS INC | 10,736,000 | $54,968 | 6.3% | $4.64 | -46.8% | COMM | 87583X109 |
| COGT | COGENT BIOSCIENCES INC | 6,964,375 | $50,004 | 5.7% | $9.05 | -38.7% | COMM | 19240Q201 |
| OCUL | OCULAR THERAPEUTIX INC | 5,319,148 | $49,362 | 5.6% | $7.10 | +10.3% | COMM | 67576A100 |
| — | CIDARA THERAPEUTICS INC | 1,005,901 | $48,997 | 5.6% | $25.94 | — | COMM | 171757206 |
| ABVX | ABIVAX SA AMERICAN DEPOSITARY SHARES | 6,056,596 | $46,333 | 5.3% | $12.76 | — | ADRS | 00370M103 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 5,943,812 | $38,100 | 4.4% | $2.53 | +91.9% | COMM | 03237H101 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 2,890,816 | $37,985 | 4.3% | $7.22 | — | ADRS | 152309100 |
| FULC | FULCRUM THERAPEUTICS INC | 5,250,000 | $36,120 | 4.1% | $7.42 | -27.9% | COMM | 359616109 |
| DYN | DYNE THERAPEUTICS INC | 3,766,660 | $35,859 | 4.1% | $14.96 | -26.4% | COMM | 26818M108 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 3,572,335 | $33,616 | 3.8% | $10.51 | -34.3% | COMM | 30233G209 |
| UPB | UPSTREAM BIO INC | 2,801,763 | $30,763 | 3.5% | $22.33 | -58.6% | COMM | 91678A107 |
| SVRA | SAVARA INC | 12,362,205 | $28,186 | 3.2% | $3.73 | -27.2% | COMM | 805111101 |
| DNTH | DIANTHUS THERAPEUTICS INC | 1,501,624 | $27,975 | 3.2% | $25.71 | -27.0% | COMM | 252828108 |
| TYRA | TYRA BIOSCIENCES INC | 2,898,103 | $27,735 | 3.2% | $12.78 | -25.6% | COMM | 90240B106 |
| IRON | DISC MEDICINE INC | 465,257 | $24,640 | 2.8% | $33.98 | +38.2% | COMM | 254604101 |
| — | TOURMALINE BIO INC | 1,477,593 | $23,627 | 2.7% | $25.14 | — | COMM | 89157D105 |
| AGIO | Agios Pharmaceuticals, Inc. | 697,003 | $23,182 | 2.6% | $30.31 | 0.0% | COMM | 00847X104 |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,063,000 | $22,047 | 2.5% | $43.45 | — | ADRS | 86366E106 |
| XNCR | XENCOR INC | 2,452,138 | $19,274 | 2.2% | $18.82 | -52.3% | COMM | 98401F105 |
| SLN | SILENCE THERAPEUTICS PLC | 3,033,560 | $17,595 | 2.0% | $14.21 | — | ADRS | 82686Q101 |
| SLNO | SOLENO THERAPEUTICS INC | 186,250 | $15,604 | 1.8% | $47.87 | +56.3% | COMM | 834203309 |
| — | ASTRIA THERAPEUTICS INC | 2,761,861 | $14,804 | 1.7% | $14.07 | — | COMM | 04635X102 |
| RAPT | RAPT Therapeutics, Inc. | 1,636,275 | $13,090 | 1.5% | $7.63 | 0.0% | COMM | 75382E208 |
| — | THIRD HARMONIC BIO INC | 1,915,424 | $10,401 | 1.2% | $13.43 | — | COMM | 88427A107 |
| ELVN | Enliven Therapeutics, Inc. | 498,000 | $9,990 | 1.1% | $18.93 | 0.0% | COMM | 29337E102 |
| MBX | MBX BIOSCIENCES INC | 650,000 | $7,417 | 0.8% | $22.87 | -55.5% | COMM | 55287L101 |
| NKTR | NEKTAR THERAPEUTICS | 266,666 | $6,891 | 0.8% | $11.24 | 0.0% | COMM | 640268306 |
| VTGN | VISTAGEN THERAPEUTICS INC | 2,676,580 | $5,353 | 0.6% | $3.41 | -33.4% | COMM | 92840H400 |
| KOD | KODIAK SCIENCES INC | 1,145,538 | $4,273 | 0.5% | $4.16 | -15.0% | COMM | 50015M109 |
| KURA | KURA ONCOLOGY INC | 735,184 | $4,242 | 0.5% | $14.54 | -57.9% | COMM | 50127T109 |
| TRDA | ENTRADA THERAPEUTICS INC | 584,955 | $3,931 | 0.4% | $17.12 | — | COMM | 29384C108 |
| — | ADVERUM BIOTECHNOLOGIES INC | 1,796,482 | $3,862 | 0.4% | $7.02 | — | COMM | 00773U207 |
| AVTX | AVALO THERAPEUTICS INC | 483,000 | $2,410 | 0.3% | $10.31 | -54.7% | COMM | 05338F306 |
| VTYX | VENTYX BIOSCIENCES INC | 316,195 | $677 | 0.1% | $29.94 | -94.6% | COMM | 92332V107 |
| JBIO | JADE BIOSCIENCES INC | 64,023 | $640 | 0.1% | $33.31 | 0.0% | COMM | 008064206 |
| CABA | CABALETTA BIO INC | 86,795 | $132 | 0.0% | $3.64 | -57.2% | COMM | 12674W109 |